Christal Mickle
Founder bij ZEVRA THERAPEUTICS, INC.
Vermogen: 772 508 $ op 31-03-2024
Actieve functies van Christal Mickle
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 10-10-2023 | - |
| Founder | 30-10-2006 | - | |
| Director/Board Member | 30-10-2006 | 15-04-2015 | |
| Chief Executive Officer | 01-06-2023 | 10-10-2023 | |
| Chief Operating Officer | 30-10-2006 | 11-01-2023 | |
| Investor Relations Contact | 30-10-2006 | - | |
| Public Communications Contact | 18-09-2009 | - | |
| President | 01-06-2023 | 10-10-2023 | |
| Corporate Secretary | 30-10-2006 | - | |
| Treasurer | 30-10-2006 | - |
Loopbaan van Christal Mickle
Eerdere bekende functies van Christal Mickle
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01-01-2002 | 01-01-2005 |
Opleiding van Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Beurs
- Insiders
- Christal Mickle
- Ervaring
